Orthopedic Alerts for Patients - Implant Recalls

Alerts and implant recalls for patients with orthopedic bone and joint conditions.

Japanese pharmaceutical company Takeda is scrambling to recover as its once top-selling diabetes drug, Actos, loses market share to generic versions and as Actos lawsuits continue to mount. Over the six-month period ending Sept. 30, 2012, sales of Actos decreased 46.2 percent from the previous year. From 2011 to 2012, Takeda estimates that sales of [...]

Read more ...

Victims of a catastrophic storm, such as Hurricane Sandy, have many immediate needs with food, shelter and transportation. It’s critical, though, that they not put off planning for adequate medicine supplies in the days before and after the natural disaster. Many of today’s insurance companies limit the quantities of drugs that can be purchased in [...]

Read more ...

Pregnant women who are suffering from depression should avoid antidepressant drugs until their babies are born, two experienced doctors say in their paper published this week in the journal Human Reproduction. After reviewing an abundance of scientific data, the medical professionals concluded that the risks of a popular class of antidepressants, selective serotonin reuptake inhibitors [...]

Read more ...

Obese people face more risks than other patients when it comes to total knee replacement (TKR) surgery and need to have revision operations more often than other patients, according to a new study published in the Journal of Bone and Joint Surgery. Being overweight puts extra stress on the joints, such as the knees, and [...]

Read more ...

To ASR Hip Replacement Patients: At DePuy, our mission for more than a century has been developing products and technologies that help patients who have been impacted by pain, disability and a loss of mobility return to a more active lifestyle. If DePuy finds that one of its products is not meeting the high standards of our company, our patients, or our surgeons’, we take appropriate action. In August 2010, DePuy issued a voluntary recall of our ASR™ Hip System after receiving new, then-unpublished data from a joint replacement registry in the UK. This data indicated that while the vast majority of patients with the ASR Hip System were not experiencing any problems, a higher number of ASR patients than previously reported to DePuy needed a second surgery, called a revision surgery, earlier than expected.

Read more ...